Regulation of multiple angiogenic signaling and development of cancer-specific gene therapy
Regulation of multiple angiogenic signaling and development of cancer-specific gene therapy
批准号:
12671164
负责人:
TANAKA Shinji
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
我们之前报道过血管生成素(Angiopoietin, Ang),一种Tie2血管内皮特异性受体酪氨酸激酶的配体,可能在人类肝细胞癌(HCC)的进展中发挥作用,HCC通常以快速生长的高血管肿瘤为特征(J clininvest 1999)和基质蛋白酶表达(Cancer Res 2001)。然而,Tie2受体在肝癌发生中的作用尚不清楚。免疫组化结果显示,Tie2受体蛋白在31/39(80%)人肝癌肿瘤的新生血管内皮中过表达,且与细胞去分化和肿瘤大小有显著相关性(p<0.05)。在体外表达含有可溶性Tie2外结构域(sTie2)的显性阴性构建体,导致Ang蛋白相互作用,抑制血管内皮细胞内源性Tie2磷酸化,抑制基质金属蛋白酶-9 (MMP-9)。体内基因转移和肝细胞癌模型中sTie2的表达抑制了肝细胞癌新生血管形成的致瘤性。更多尿液肝细胞癌模型表明,Tie2表达可能在肝细胞癌新生血管形成和疾病进展中起作用(《肝病》杂志)。更重要的是,抑制Ang/Tie2信号转导级联是一种很有前途的肿瘤治疗方法。通过靶向差异显示,我们发现了CCN家族成员WISP1 (wnt诱导分泌蛋白1)的一种新变体,命名为WISP1v,在硬膜性胃癌中过度表达。新出现的CCN基因家族成员(用于结缔组织生长因子,富含半胱氨酸61,肾母细胞瘤过度表达)编码富含半胱氨酸的分泌蛋白,在人类纤维化疾病和癌症血管生成中发挥作用。预测的WISP1 v蛋白完全缺乏被认为参与蛋白复合物形成的Von Willebrand C型模块。异位表达表明WISP1 v是一种分泌的癌蛋白,可诱导显著的细胞转化和快速堆积生长。值得注意的是,WISP1 v转染物增强了共培养胃癌细胞的侵袭性表型,而野生型WISP1则没有这种潜力。这些发现提示CCN蛋白WISP1 v参与了黏液性胃癌的侵袭性进展。少
英文摘要
We have previously reported that Angiopoietin (Ang), a ligand for Tie2 vascular endothelial-specific receptor tyrosine kinase, may play a role in the progression of human hepatocellular carcinoma (HCC) is generally characterized as a hypervascular tumor of rapid growth (J Clin Invest 1999) and matrix proteinase expression (Cancer Res 2001). However, the role of Tie2 receptor in hepatic oncogenesis is unknown. The Tie2 receptor protein was overexpressed in the neovascular endothelium of 31/39 (80%) human HCC tumors by immunohistochemical analysis with significant correlation to cell dedifferentiation and tumor size (p<0.05). In vitro expression of a dominant-negative construct, containing a soluble Tie2 ectodomain (sTie2), led to Ang protein interaction, inhibition of endogeneous Tie2 phosphorylation in vascular endothelial cells, and matrix metalloproteinase-9 (MMP-9) suppression. Tumorigenicity with neovascularization was suppressed by in vivo gene transfer and sTie2 expression in a m … More urine HCC model suggesting a possible role for Tie2 expression in the induction of HCC neovascularization, and disease progression (Hepatology (in press)). More important, inhibition of the Ang/Tie2 signal transduction cascade is a promising approach for tumor treatment.Using targeted differential displays, we identified a novel variant of the CCN family member WISP1 (Wnt-induced secreted protein 1), named WISP1v, as overexpressed in scirrhous gastric carcinomas. Members of the emerging family of the CCN gene (for connective tissue growth factor, cysteine-rich 61, nephroblastoma overexpressed) encode cysteine-rich secreted proteins with roles in human fibrotic disorders and cancer angiogenesis. Predicted protein of the WISP1 v completely lacks a module of Von Willebrand type C that is thought to participate in protein complex formation. Ectopic expression revealed WISP1 v to be a secreted oncoprotein inducing a striking cellular transformation and rapid piling-up growth. It is noteworthy that WISP1 v transfectants enhanced the invasive phenotype of co-cultured gastric carcinoma cells, while wild-type WISP1 had no such potential. These findings suggest that CCN protein WISP1 v is involved in the aggressive progression of scirrhous gastric carcinoma. Less
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tanaka S, Sugimachi K, Saeki H, Kinoshita J, Ohga T, Shimada M, Maehara Y, Sugimachi K: "A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in cirrhous gastric carcinoma"Oncogene. 20(39). 5525-32 (2001)
Tanaka S、Sugimachi K、Saeki H、Kinoshita J、Ohga T、Shimada M、Maehara Y、Sugimachi K:“缺乏 Von Willebrand C 型模块的 WISP1 的新型变体,在肝硬化胃癌中过度表达”癌基因。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamashita Yi, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Shimada M, Sugimachi K: "Bile Leakage After Hepatic Resection"Annals of Surgery. 233(1). 45-50 (2001)
Yamashita Yi、Hamatsu T、Rikimaru T、Tanaka S、Shirabe K、Shimada M、Sugimachi K:“肝切除术后胆漏”外科年鉴。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka S, Sugimachi K, Kawaguchi H, Saeki H, Ohno S, Wands JR, Sugimachi K: "Grb7 signal transduction protein mediates metastatic progression of esopahgeal carcinoma"Journal of Cellular Physiology. 183(3). 411-415 (2000)
Tanaka S、Sugimachi K、Kawaguchi H、Saeki H、Ohno S、Wands JR、Sugimachi K:“Grb7 信号转导蛋白介导食管癌的转移进展”细胞生理学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimada M, Hashizume M, Maehara S, Tsujita E, Rikimaru T, Yamashita Y, Tanaka S, Adachi E, Sugimachi K: "Laparoscopic hepatectomy for hepatocellular carcinoma"Surgical Encoscopy. 15. 541-4 (2001)
Shimada M、Hashizume M、Maehara S、Tsujita E、Rikimaru T、Yamashita Y、Tanaka S、Adachi E、Sugimachi K:“肝细胞癌的腹腔镜肝切除术”外科内窥镜检查。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sugimachi K, Maehara S, Tanaka S, Shimada M, Sugimachi K: "Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma"Journal of Hepatobiliary Pancreatic Surgery. 8(5). 410-6 (2001)
Sugimachi K、Maehara S、Tanaka S、Shimada M、Sugimachi K:“重复肝切除术是复发性肝细胞癌最有效的治疗方法”《肝胆胰外科杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 36 条
学校安全の推進の為の組織的対応力の向上を目指した校内研修プログラムの開発
-
批准号:21H03974
-
项目类别:Grant-in-Aid for Encouragement of Scientists
-
资助金额:$0.28万
-
财政年份:2021
-
负责人:TANAKA Shinji
-
依托单位:
安全に関する資質・能力を身に着けることを目指した、安全教育カリキュラムの構築
-
批准号:19H00081
-
项目类别:Grant-in-Aid for Encouragement of Scientists
-
资助金额:$0.33万
-
财政年份:2019
-
负责人:TANAKA Shinji
-
依托单位:
Virtue Ethics in Plato's Politeia
-
批准号:18K00011
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.25万
-
财政年份:2018
-
负责人:TANAKA Shinji
-
依托单位:
Develoment of advanced therapy targeting tumor heterogeneity in refractory cancers
-
批准号:16H02670
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.28万
-
财政年份:2016
-
负责人:TANAKA Shinji
-
依托单位:
Development of chiral picolinic acid-type ligand and application for saymmetric catalysis
-
批准号:25410112
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2013
-
负责人:TANAKA Shinji
-
依托单位:
Experimental verification of the model of concentration change in lubricating film by measuring the distribution of the refrigerant concentration dissolved in the lubricating film
-
批准号:23560154
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:TANAKA Shinji
-
依托单位:
Study on the establishment of the unified international NBI magnification classification for colorectal tumor
-
批准号:22590762
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.58万
-
财政年份:2010
-
负责人:TANAKA Shinji
-
依托单位:
Catalytic Asymmetric Synthesis of Chiral Cyclic Ethers
-
批准号:22750088
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:TANAKA Shinji
-
依托单位:
Innovation of cancer treatment based on the refractory mechanism
-
批准号:22249050
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.7万
-
财政年份:2010
-
负责人:TANAKA Shinji
-
依托单位:
Truth and the structure of Socratic dialectic
-
批准号:21520008
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.83万
-
财政年份:2009
-
负责人:TANAKA Shinji
-
依托单位:
Omics analysis of cancer vessel abnormalities as therapeutic targets
-
批准号:19390346
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2007
-
负责人:TANAKA Shinji
-
依托单位:
Analysis of novel angiogenesis-related genes and development of tumor dormancy therapy
-
批准号:17390371
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2005
-
负责人:TANAKA Shinji
-
依托单位:
Study on Psyche' in the Ancient Greek Philosophy
-
批准号:17320004
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.15万
-
财政年份:2005
-
负责人:TANAKA Shinji
-
依托单位:
Analysis of newly identified anglogenic genes and the signal inhibition for tumor dormancy therapy
-
批准号:14571141
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:TANAKA Shinji
-
依托单位:
Socratic Inquiry in Plato's Early Philosophy : Dialectic Structure and its significance of today
-
批准号:13610039
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:2001
-
负责人:TANAKA Shinji
-
依托单位:
Clinicopathologic and genetic analysis on histogenesis and development of colorectal carcinoma
-
批准号:10670478
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:TANAKA Shinji
-
依托单位:
Clinicopathologic and molecular biologic study on histogenesis and development of colorectal carcinoma
-
批准号:08670596
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1996
-
负责人:TANAKA Shinji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
METTL3以m6A-HuR依赖性调控ETS1/Tie2促进乳牙干细胞诱导血管生成的机制研究
-
批准号:2025JJ80529
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:覃建
-
依托单位:
Tie2通过靶向NLRP3泛素化调控巨噬细胞焦亡和NLRP3炎症小体激活改善急性肺损伤的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:徐佳妮
-
依托单位:
血管内皮细胞TIE2突变通过调控TNFSF10-BK/Ca离子通道影响静脉畸形平滑肌细胞表型转化过程的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:王延安
-
依托单位:
积雪草苷靶向Sirt3/Ang1/Tie2信号轴介导周细胞—内皮细胞间通讯阻抑腹膜微血管损伤
-
批准号:82305226
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:唐蕾
-
依托单位:
基于凝血级联-VEGFA-Ang1/Tie2通路协同机制的蒲黄炭炮制机理及物质基础研究
-
批准号:82374037
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:陈佩东
-
依托单位:
房水动力学靶向Schlemm管内皮细胞TIE2信号调节小梁网干细胞“干性”的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:徐丽娟
-
依托单位:
益气养阴活血通络法调控周细胞-内皮细胞Ang/Tie2信号恢复内皮生态位改善血管通透性治疗IPF机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:吕晓东
-
依托单位:
PROX-1介导的内皮细胞特异性敲除Tie2对血管稳态维持的影响与作用机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:储蔓
-
依托单位:
酪氨酸激酶受体2(TIE2)与结核病肉芽肿免疫机制的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:曲胜华
-
依托单位:
Tie2受体激活在软组织肉瘤中诱导抗血管生成耐药的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张星
-
依托单位: